prostate-cancer

Documents about prostate-cancer

• Stratagen Quantitative Prostate MRI Platform Pilot Study#802340ClinicalTrials.gov
• A prostate-specific membrane antigen targeted small molecule-drug conjugate for efficient prostate cancer therapy at a low dosage#5310Europe PMC
• Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT#845819ClinicalTrials.gov
• A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse#800644ClinicalTrials.gov
• Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer#349961ClinicalTrials.gov
• A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer#363622ClinicalTrials.gov
• A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer#369883ClinicalTrials.gov
• Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach#805567ClinicalTrials.gov
• Application of DWI in Diagnosis of Prostate Cancer#825464ClinicalTrials.gov
• Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer Patients#829327ClinicalTrials.gov
• The Metformin Active Surveillance Trial (MAST) Study#832028ClinicalTrials.gov
• MR-simulation in Radiotherapy for Prostate Cancer#832252ClinicalTrials.gov
• Effectiveness of Community-based Football in Prostate Cancer#839694ClinicalTrials.gov
• 99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer#843462ClinicalTrials.gov
• Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing#845138ClinicalTrials.gov
• Cancer Statistics, 2009#7189OpenAlex
• Prevalence of homologous recombination repair genes alterations in metastatic castration-resistant prostate cancer, a multicentric study#330213HAL (France)
• Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients#801228ClinicalTrials.gov
• Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer#807107ClinicalTrials.gov
• Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era#826124ClinicalTrials.gov
• An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies#833045ClinicalTrials.gov
• Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy#160339ClinicalTrials.gov
• Sexually and non-sexually transmitted infections and the risk of prostate cancer: Results from the EPICAP study#178039HAL (France)
• Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy#828699ClinicalTrials.gov
• Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance#208460ClinicalTrials.gov
• Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer#268092ClinicalTrials.gov
• Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)#373738ClinicalTrials.gov
• Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer#425634Repositorio Institucional de la Universidad de Granada
• Heterogeneity of Tertiary Lymphoid Structures Predicts Distinct Malignancy and Immune Microenvironment in Prostate Cancer: a Retrospective Cohort Study#442098ClinicalTrials.gov
• Two susceptibility loci identified for prostate cancer aggressiveness.#486335University of Ghana Digital Collections (UGSpace)
• An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer#804195ClinicalTrials.gov
• Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer#811329ClinicalTrials.gov
• Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients#828628ClinicalTrials.gov
• WATER IV PCa (AS Sub-study)#838026ClinicalTrials.gov
• To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients#838474ClinicalTrials.gov
• Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy#845772ClinicalTrials.gov
• Comparing the effectiveness of prostate cancer screening protocols: European Association of Urology- and European Randomized Study of Screening for Prostate Cancer-based strategies#224182Europe PMC
• Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)#836712ClinicalTrials.gov
• A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer#839838ClinicalTrials.gov
• Prostate Adenocarcinoma TransCutaneous Hormones#325231ClinicalTrials.gov
• Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study#838217ClinicalTrials.gov
• Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer#838105ClinicalTrials.gov
• Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients#839208ClinicalTrials.gov
• Cancer statistics, 2020#6824OpenAlex
• A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer#838955ClinicalTrials.gov
• Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer#841818ClinicalTrials.gov
• Pilot Study of DRibble Vaccine for Prostate Cancer Patients#810964ClinicalTrials.gov
• To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence#805330ClinicalTrials.gov
• Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy#807663ClinicalTrials.gov
• Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients#807854ClinicalTrials.gov